Cargando…
Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes
BACKGROUND: The reno-protective effect of second-line treatments in type 2 diabetes has been assessed by clinical trials but generalizability to routine clinical practice is still uncertain. We aimed to assess the effectiveness of these treatments, when added to metformin, on the risk of chronic kid...
Autores principales: | Siriyotha, Sukanya, Lukkunaprasit, Thitiya, Looareesuwan, Panu, Nimitphong, Hataikarn, McKay, Gareth J., Attia, John, Thakkinstian, Ammarin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670521/ https://www.ncbi.nlm.nih.gov/pubmed/36397062 http://dx.doi.org/10.1186/s12933-022-01641-2 |
Ejemplares similares
-
Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial
por: Siriyotha, Sukanya, et al.
Publicado: (2023) -
Causal Associations of Urate With Cardiovascular Risk Factors: Two-Sample Mendelian Randomization
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2021) -
An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2023) -
The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2020) -
Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry
por: Siriyotha, Sukanya, et al.
Publicado: (2023)